Saudi Drug Authority, China’s National Medical Products Administration sign MoU for regulatory collaboration

BEIJING — The Saudi Food and Drug Authority (SFDA) signed a Memorandum of Understanding (MoU) on Friday with China’s National Medical Products Administration (NMPA) in Beijing, aiming to enhance cooperation in regulatory matters.

The agreement was signed by SFDA’s CEO Dr. Hisham Aljadhey and NMPA Commissioner Li Li, with Saudi Arabia’s Ambassador to China, Abdulrahman Al-Harbi, in attendance.

The MoU focuses on sharing regulatory information related to medicines, medical devices, and cosmetics, covering laws, regulations, and best practices. This partnership highlights the SFDA’s commitment to bolstering international cooperation through strategic alliances.

This agreement coincides with Dr. Aljadhey’s visit to China, where he will lead the Saudi delegation at the 8th Shenzhen Food Safety Forum, scheduled for November 5-6, 2024. — SG